Interestingly, the tumor suppressor MEG3 promotes tumor progression through targeting miR-4261, modulating the expression of DKK2, β-catenin, Bcl-2, and c-Myc, thus activating the Wnt/β-catenin signaling pathway [12] (Figure 4). The gene discussed is MEG3; the disease is neoplasm.